Back to RIGL
GOLDMAN SACHS GROUP INC → RIGL
GOLDMAN SACHS GROUP INC RIGL Position History
Rigel Pharmaceuticals, Inc.
Quarters held
12
Latest value
$3.4M
Q2 2026
Peak value
$22.4M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $1.3M |
| Q2 2025 | $2.1M |
| Q3 2025 | $13.8M |
| Q3 2025 | $7M |
| Q4 2025 | $22.4M |
| Q4 2025 | $6.4M |
| Q4 2025 | $6.4M |
| Q4 2025 | $22.4M |
| Q1 2026 | $4.5M |
| Q1 2026 | $7.4M |
| Q2 2026 | $5.5M |
| Q2 2026 | $3.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $3.4M | 86.0K | — | — |
| Q2 2026 | $5.5M | 140.8K | — | — |
| Q1 2026 | $7.4M | 274.5K | — | — |
| Q1 2026 | $4.5M | 164.6K | — | — |
| Q4 2025 | $22.4M | 522.3K | — | — |
| Q4 2025 | $6.4M | 149.6K | — | — |
| Q4 2025 | $6.4M | 149.6K | — | — |
| Q4 2025 | $22.4M | 522.3K | — | — |
| Q3 2025 | $7M | 248.8K | — | — |
| Q3 2025 | $13.8M | 488.3K | — | — |
| Q2 2025 | $2.1M | 114.6K | — | — |
| Q2 2025 | $1.3M | 67.7K | — | — |
Other funds holding RIGL
$40.7M
$40.7M
$30.3M
$15.1M
$13.2M
$12.9M
$11.6M